Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 2041 AL 2055

The relationships of vitamin D, vitamin D receptor gene polymorphisms, and vitamin D supplementation with Parkinson's disease

Lv L, Tan X, Peng X, Bai R, Xiao Q, Zou T, Tan J, Zhang H, Wang C.

Transl Neurodegener. 2020 Sep 1;9(1):34. doi: 10.1186/s40035-020-00213-2.

Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms

Mohammadi S, Moosaie F, Aarabi MH.

Mol Neurobiol. 2020 Dec;57(12):5263-5275. doi: 10.1007/s12035-020-02094-y. Epub 2020 Sep 1.

Safety considerations when using non-ergot dopamine agonists to treat Parkinson's disease

Stocchi F, Fossati B, Torti M.

Expert Opin Drug Saf. 2020 Sep;19(9):1155-1172. doi: 10.1080/14740338.2020.1804550. Epub 2020 Oct 3.

GDNF/RET signaling in dopamine neurons in vivo

Conway JA, Ince S, Black S, Kramer ER.

Cell Tissue Res. 2020 Oct;382(1):135-146. doi: 10.1007/s00441-020-03268-9. Epub 2020 Sep 1.

Inflammatory effects of particulate matter air pollution

Arias-Pérez RD, Taborda NA, Gómez DM, Narvaez JF, Porras J, Hernandez JC.

Environ Sci Pollut Res Int. 2020 Dec;27(34):42390-42404. doi: 10.1007/s11356-020-10574-w. Epub 2020 Sep 1.

Improved Parkinsons disease motor score in a single-arm open-label trial of febuxostat and inosine

Watanabe H, Hattori T, Kume A, Misu K, Ito T, Koike Y, Johnson TA, Kamitsuji S, Kamatani N, Sobue G.

Medicine (Baltimore). 2020 Aug 28;99(35):e21576. doi: 10.1097/MD.0000000000021576.

Structured Care and Self-Management Education for Persons with Parkinson's Disease: Why the First Does Not Go without the Second-Systematic Review, Experiences and Implementation Concepts from Sweden and Germany

Tennigkeit J, Feige T, Haak M, Hellqvist C, Seven ÜS, Kalbe E, Schwarz J, Warnecke T, Tönges L, Eggers C, Loewenbrück KF.

J Clin Med. 2020 Aug 28;9(9):2787. doi: 10.3390/jcm9092787.

Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson's Disease: A Perspective on Associated Therapeutic Interventions

Behl T, Kaur G, Bungau S, Jhanji R, Kumar A, Mehta V, Zengin G, Brata R, Hassan SSU, Fratila O.

Int J Mol Sci. 2020 Aug 28;21(17):6235. doi: 10.3390/ijms21176235.

Clinical Effectiveness and Adverse Events of Bee Venom Therapy: A Systematic Review of Randomized Controlled Trials

Jang S, Kim KH.

Toxins (Basel). 2020 Aug 29;12(9):558. doi: 10.3390/toxins12090558.

A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier

Cortés H, Alcalá-Alcalá S, Caballero-Florán IH, Bernal-Chávez SA, Ávalos-Fuentes A, González-Torres M, González-Del Carmen M, Figueroa-González G, Reyes-Hernández OD, Floran B, Del Prado-Audelo ML, Leyva-Gómez G.

Membranes (Basel). 2020 Aug 30;10(9):212. doi: 10.3390/membranes10090212.

Early Biomarkers of Neurodegenerative and Neurovascular Disorders in Diabetes

Gasecka A, Siwik D, Gajewska M, Jaguszewski MJ, Mazurek T, Filipiak KJ, Postuła M, Eyileten C.

J Clin Med. 2020 Aug 30;9(9):2807. doi: 10.3390/jcm9092807.

Application of the '5-2-1' screening criteria in advanced Parkinson's disease: interim analysis of DUOGLOBE

Aldred J, Anca-Herschkovitsch M, Antonini A, Bajenaru O, Bergmann L, Bourgeois P, Cubo E, Davis TL, Iansek R, Kovács N, Kukreja P, Onuk K, Pontieri FE, Robieson W, Siddiqui MS, Simu M, Standaert DG, Chaudhuri KR.

Neurodegener Dis Manag. 2020 Oct;10(5):309-323. doi: 10.2217/nmt-2020-0021. Epub 2020 Sep 2.

A novel RAB39B mutation and concurrent de novo NF1 mutation in a boy with neurofibromatosis type 1, intellectual disability, and autism: a case report

Santoro C, Giugliano T, Bernardo P, Palladino F, Torella A, Del Vecchio Blanco F, Onore ME, Carotenuto M, Nigro V, Piluso G.

BMC Neurol. 2020 Sep 1;20(1):327. doi: 10.1186/s12883-020-01911-0.

Abstracts of the IAPRD XXV World Congress on Parkinson's Disease and Related Disorders, 2020. Congress theme: Diagnosing and treating movement disorders in the era of personalized medicine

Fujioka S, Puschmann A.

Parkinsonism Relat Disord. 2020 Jul 27;79:e1-e2. doi: 10.1016/j.parkreldis.2020.06.038. Online ahead of print.

Targeting Vesicular Glutamate Transporter Machinery: Implications on Metabotropic Glutamate Receptor 5 Signaling and Behavior

Ibrahim KS, Abd-Elrahman KS, El Mestikawy S, Ferguson SSG.

Mol Pharmacol. 2020 Oct;98(4):314-327. doi: 10.1124/molpharm.120.000089.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias